ArticlePsychiatry investigation2026
Paraben and Phthalate Exposure in Adolescents With Attention-Deficit/Hyperactivity Disorder: A Case-Control Study.
Article in Psychiatry investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis case-control study compared urinary concentrations of parabens and phthalate metabolites between adolescents with attention-deficit/hyperactivity disorder (ADHD) and healthy peers and examined whether product-use behaviors accounted for observed exposure differences.
methodsAdolescents aged 12-17 years with clinically diagnosed ADHD (n=39) and age- and sex-matched healthy controls (n=41) were recruited. Urinary concentrations of seven parabens and ten phthalate metabolites were quantified using validated high-performance liquid chromatography and gas chromatography-mass spectrometry protocols. ADHD symptoms were assessed using Conners Parent and Adolescent Rating Scales. Group comparisons were conducted using t-tests with effect sizes (Cohen's d). Multivariable logistic regression, factorial analysis of covariance (ANCOVA) models (reporting partial η²), and multiple mediation analyses were performed, adjusting for household income, parental education, and body mass index.
resultsDifferences in the urinary concentrations of several parabens and phthalate metabolites were observed between adolescents with ADHD and controls. However, detection frequencies varied across analytes, and findings for compounds with low detection frequency should be interpreted with caution. In multivariable logistic regression, an association between dimethyl phthalate and ADHD status was observed (odds ratio=6.13; 95% confidence interval, 1.10-34.34), with improved model discrimination (Δχ²=17.2, p=0.002; area under the receiver operating characteristic curve, 0.856→0.921); however, this finding should be interpreted with caution given its low detection frequency. In ANCOVA models adjusting for product-use behaviors, group differences remained significant only for dimethyl phthalate (F(1, 71)=7.97, p=0.006, η²=0.099); however, this finding should likewise be interpreted with caution due to its low detection frequency. Mediation analyses indicated that recent personal care product use did not substantially mediate the association between ADHD status and chemical exposure levels.
conclusionAdolescents with ADHD showed differences in internal exposure to selected parabens and phthalate metabolites. These findings should be interpreted with caution, particularly for analytes with low detection frequency. Overall, these findings suggest that exposure differences may reflect behavior-linked vulnerability patterns during adolescence rather than short-term cosmetic use alone. Longitudinal studies are needed to clarify temporal and causal pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.